4.5 Article

Feedback loop between fatty acid transport protein 2 and receptor interacting protein 3 pathways promotes polymorphonuclear neutrophil myeloid-derived suppressor cells-potentiated suppressive immunity in bladder cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy

Adeleye Oluwatosin Adeshakin et al.

Summary: The success of cancer immunotherapy using PD-L1 blockade may be enhanced by targeting FATP2 in MDSCs to reduce lipid accumulation and inhibit immunosuppressive activity. This approach shows promising results in enhancing anti-PD-L1 tumor immunotherapy.

CELLULAR IMMUNOLOGY (2021)

Article Immunology

Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice

Filippo Veglia et al.

Summary: In this study, the heterogeneity of polymorphonuclear neutrophils (PMNs) in cancer was characterized using various methods, revealing different populations of PMNs. Evidence was provided to show that PMN-MDSCs are a distinct population of PMNs with unique features and potential for selective targeting opportunities.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

Interferon Regulatory Factor 4 Regulates the Development of Polymorphonuclear Myeloid-Derived Suppressor Cells Through the Transcription of c-Myc in Cancer

Quan Yang et al.

Summary: This study shows that IRF4 plays a crucial role in the development of PMN-MDSCs, and its deficiency can lead to an increase in PMN-MDSCs and enhanced suppressive activity, promoting tumor growth and metastasis. There is a correlation between the expression levels of IRF4 and c-Myc in clinical cancer patients, which may have predictive value for tumor progression.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma

Ying Wang et al.

Summary: This study investigated the immune cell profiles in AEG tissues and found high levels of CD8(+) T cells, M0, and M2 macrophages. PMN-MDSCs were identified as the predominant subtype in tumor sites. Elevated levels of MDSCs, especially PMN-MDSCs, were associated with advanced cancer staging, low grade, lymph node metastasis, and HER2(-) status, indicating their potential clinical significance in AEG.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis

Qun Zhao et al.

Summary: RIPK3 plays a critical role in the progression of spontaneous intestinal tumorigenesis, and its deficiency can enhance tumor formation. Reduced expression of RIPK3 is associated with poor prognosis in CRC patients.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization

Christopher Groth et al.

Summary: This review summarizes the origin of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) and their relation to classical neutrophils, outlining their metastasis promoting features and promising strategies for targeting them to enhance the efficacy of cancer immunotherapy.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment

Han-Hee Park et al.

Summary: The study identifies TRIM28 as a co-repressor regulating transcriptional activity during necroptosis. Activated RIPK3 phosphorylates TRIM28, inhibiting its chromatin binding activity and contributing to increased cytokine expression and immunoregulatory processes. RIPK3 activation-dependent derepression of TRIM28 in cancer cells leads to enhanced immunostimulatory cytokine production and robust anti-tumor immunity.

MOLECULAR CANCER (2021)

Review Immunology

Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

Kyohei Nakamura et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Review Pharmacology & Pharmacy

FATP2-targeted therapies - A role beyond fatty liver disease

Peishan Qiu et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Multidisciplinary Sciences

Fatty acid transport protein 2 reprograms neutrophils in cancer

Filippo Veglia et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

PGE2 in fibrosis and cancer: Insights into fibroblast activation

Eiman Elwakeel et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2019)

Editorial Material Immunology

RIPK3: Beyond Necroptosis

Azia S. Evans et al.

IMMUNITY (2019)

Article Medicine, Research & Experimental

RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer

Nikolay Conev et al.

CLINICAL AND INVESTIGATIVE MEDICINE (2019)

Article Critical Care Medicine

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer

Yoshikane Yamauchi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Immunology

Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression

Kim Ohl et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Immunology

Tumor-Associated Macrophages as Target for Antitumor Therapy

Katarzyna Sawa-Wejksza et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)

Review Immunology

Suppression of T cells by myeloid-derived suppressor cells in cancer

Jieying Chen et al.

HUMAN IMMUNOLOGY (2017)

Article Cell Biology

Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner

Rikke B. Holmgaard et al.

CELL REPORTS (2015)